ArticlePublisher preview available

The incidence and outcome of chondral tumours as incidental findings on investigation of shoulder pathology

Authors:
To read the full-text of this research, you can request a copy directly from the authors.

Abstract and Figures

Purpose The aim of this study is to describe outcomes of incidental chondral tumours in the shoulder referred to our Bone Tumour Unit (BTU). Methods Our hospital radiology database was searched using the filtered terms “enchondroma”, “low-grade chondral tumour”, “chondrosarcoma” with “humerus”, “arm”, “shoulder”, “scapula” and “clavicle”. Case note review of results assessed primary reasons for referral, radiological diagnosis, recommended management with subsequent reviews and outcomes, either in clinic or surveillance scan reports. Results Ninety-nine patients had full case note review, mean age 54.5 years (range 18–84 years). Mean follow-up was 41.7 months (range 1–265 months). Over 50% of patients were referred for shoulder pain. Three patients had high-grade chondrosarcoma. Forty-three patients had interval scans, none showing any changes. Thirty-five patients had surgery for their lesions with one recurrence. Forty-four patients had alternative diagnoses made on clinical and radiological examination. At most recent follow-up, 70% of these patients were asymptomatic after physiotherapy/surgical attention to their alternative diagnoses. Conclusions Chondral lesions in the shoulder have low risk of malignant transformation and are rarely responsible for shoulder symptoms. We recommend patients be referred to a dedicated BTU for surveillance if there are any concerning features, but to proceed with management for any alternative diagnosis.
This content is subject to copyright. Terms and conditions apply.
Vol.:(0123456789)
1 3
European Journal of Orthopaedic Surgery & Traumatology (2020) 30:97–102
https://doi.org/10.1007/s00590-019-02532-1
ORIGINAL ARTICLE • SHOULDER - TUMORS
The incidence andoutcome ofchondral tumours asincidental ndings
oninvestigation ofshoulder pathology
S.S.Jassim1 · T.Hilton1· A.Saifuddin1· R.Pollock1
Received: 15 July 2019 / Accepted: 13 August 2019 / Published online: 17 August 2019
© Springer-Verlag France SAS, part of Springer Nature 2019
Abstract
Purpose The aim of this study is to describe outcomes of incidental chondral tumours in the shoulder referred to our Bone
Tumour Unit (BTU).
Methods Our hospital radiology database was searched using the filtered terms “enchondroma”, “low-grade chondral
tumour”, “chondrosarcoma” with “humerus”, “arm”, “shoulder”, “scapula” and “clavicle”. Case note review of results
assessed primary reasons for referral, radiological diagnosis, recommended management with subsequent reviews and out-
comes, either in clinic or surveillance scan reports.
Results Ninety-nine patients had full case note review, mean age 54.5years (range 18–84years). Mean follow-up was
41.7months (range 1–265months). Over 50% of patients were referred for shoulder pain. Three patients had high-grade
chondrosarcoma. Forty-three patients had interval scans, none showing any changes. Thirty-five patients had surgery for
their lesions with one recurrence. Forty-four patients had alternative diagnoses made on clinical and radiological exami-
nation. At most recent follow-up, 70% of these patients were asymptomatic after physiotherapy/surgical attention to their
alternative diagnoses.
Conclusions Chondral lesions in the shoulder have low risk of malignant transformation and are rarely responsible for
shoulder symptoms. We recommend patients be referred to a dedicated BTU for surveillance if there are any concerning
features, but to proceed with management for any alternative diagnosis.
Keywords Shoulder· Oncology· Chondrosarcoma
Introduction
The prevalence of shoulder pain in the UK population is
common. It is thought that 1–2% of adults consult their gen-
eral practitioner with new-onset shoulder pain every year [1].
The more frequent diagnoses include rotator cuff pathology,
subacromial impingement and degenerative joint disease.
Following investigation of shoulder pain with plain radio-
graphs, computed tomography (CT) and magnetic resonance
imaging (MRI), findings of incidental chondral tumours are
estimated at between 2 and 4% [2, 3]. Chondral tumours
such as enchondromas and chondrosarcomas are the more
common subtypes of bone tumours originating in the med-
ullary cavity of long bones. The most common sites are
the proximal tibia, proximal and distal femur and proximal
humerus. On their discovery, patients are typically referred
to their local bone tumour unit for further investigation and
management.
There can be uncertainty regarding their optimal manage-
ment. Enchondromas are benign lesions that do not need
surgical treatment if inactive and asymptomatic [4]. Grade
1 chondrosarcoma has been reclassified as an atypical carti-
laginous tumour as it rarely metastasizes. Surgical treatment
for both types of lesion involves curettage and local adjuvant
therapy with cement or bone graft. These procedures can
have potential complications including fracture and infec-
tion [5]. However, despite these potential morbidities, it is
estimated that 4% of solitary chondral tumours change into
secondary chondrosarcoma [6]. Therefore, some form of
surveillance is warranted.
In our Bone tumour unit (BTU), referrals of incidental
findings of such lesions are common to the multidisciplinary
team. The options for such tumours in the proximal humerus
* S. S. Jassim
shivan.jassim@doctors.org.uk
1 Bone Tumour Unit, Royal National Orthopaedic Hospital,
Brockley Hill, Stanmore, MiddlesexHA74LP, UK
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
... En cuanto al cuadro clínico, la etiología del dolor, cuando no es secundaria a compresión de estructuras que rodean la lesión, sigue sin definirse; de la misma manera, el dolor regional en el CS mimetiza al producido por trauma, lesión deportiva o condición degenerativa e inclusive se ha descrito la ausencia de dolor nocturno como dato diferenciador entre CS grado 1 comparado con los de alto grado. 14,15 Este cuadro inespecífico contribuye a la razón por la cual los pacientes presentan síntomas de larga duración que oscilan entre uno a dos años, antes de buscar tratamiento. 11 Al igual que en nuestro caso, el CS es una lesión solitaria que, cuando está localizada en escápula, consecuente a la musculatura envolvente, sólo es palpable hasta haberse tornado de gran tamaño. ...
... 11 Al igual que en nuestro caso, el CS es una lesión solitaria que, cuando está localizada en escápula, consecuente a la musculatura envolvente, sólo es palpable hasta haberse tornado de gran tamaño. 5,14 El abordaje diagnóstico del condrosarcoma necesita el uso de estudios de imagen complementarios. Las directrices actuales recomiendan radiografías simples e imágenes transversales de todo el hueso afectado (RMN) para evaluar ubicación, extensión, actividad, naturaleza cartilaginosa e identificar metástasis omitidas. ...
... Interestingly, they still recommended surveillance every 3-6 months for the first year and then annually for three years despite the fact that it took 21 months of follow-up before the earliest lesion was noted to have grown [2]. Jassim et al. suggested that patients with incidentally found enchondromas under 5cm do not require any further follow-up if they remain asymptomatic [16]. However, this recommendation was made contingent upon a 2-year period or radiographic stability, thereby supporting some degree of prolonged observation. ...
... They concluded that follow-up imaging is not required at all for incidental, nonaggressive cartilage tumors and is only recommended if the patient becomes symptomatic [1]. Taken broadly, there is agreement among numerous authors that progression is unlikely and of minimal clinical significance in the absence of symptomatology [1,2,10,16,22,23]. Still, there is little consensus concerning length of follow-up. ...
Preprint
Background: There are no established surveillance guidelines for benign bone lesions, particularly for those that do not merit surgery. It is unclear how long or how often patients should be followed, what type of radiographic studies should be obtained, and how frequency repeat imaging should be performed. Given that follow-up incurs cost, time, and resources, it is essential to better understand the probability of lesion progression and the necessity, or lack thereof, for clinical and radiographic observation. Methods A retrospective review was conducted between 2015 and 2020 of patients of all ages, races, and sexes diagnosed with a benign bone lesion after radiographic imaging. Patients diagnosed with benign bone lesions outside of the study period or not managed by an orthopedic surgeon were excluded. Outcomes included presenting symptoms, the date of visits to an orthopedic surgeon, imaging, the appearance or type of lesion, and lesion location. Patients were divided into two groups, those who were observed (Group 1) and those who underwent surgery during the duration of the study (Group 2). Both groups were subdivided into patients who were asymptomatic (Group 1a and Group 2a) or symptomatic at presentation (Group 1b and Group 2b). Descriptive statistics were used to analyze the data extracted. Results Of the 638 patients included, 10 patients (1.6%) demonstrated a change in either lesion size or morphology, 9 of which were pediatric patients. Patients in Group 1a were followed, on average, for 207.0 days and returned to the office 1.3 times after their initial visit. Patients in Group 1b were followed, on average, for 130.0 days and returned to the office 1.4 times after their initial visit. Patients in Group 2a were followed, on average, for 191.8 days and returned to the office 1.4 times after their initial visit. Patients in Group 2b were followed, on average, for 102.0 days and returned to the office 1.2 times after their initial visit. The most common imaging study obtained were plain radiographs. Patients in Group 1a received repeat imaging studies, on average, every 100.7 days while patients in Group 1b received repeat imaging studies, on average, every 69.3 days. Patients in Group 2a received repeat imaging studies, on average, every 90.3 days while patients in Group 2b received repeat imaging studies, on average, every 47.3 days. Conclusions Benign bone lesions are common incidental findings, and most require no surgical intervention. There are currently no guidelines for how long and how frequently patients should be followed, either clinically or radiographically. This study demonstrates that progression is an extremely uncommon event. Moreover, when progression does occur, it is often accompanied by clinical symptomatology. Limiting clinical and radiologic follow-up to symptomatic individuals would save most patients from incurring costs related to unnecessary clinical visits and repeat imaging studies and reduce their overall lifetime exposure to radiation. In an increasingly resource-challenged environment, routine sequential follow-up may be hard to justify. Reassuring patients and parents that access is available, if and when needed, may be helpful in managing concern while limiting cost and exposure.
Article
Chondrosarcoma is a malignant cartilage matrix-producing tumour. Those arising de novo are called primary chondrosarcomas and are the second commonest primary malignant bone tumours. Numerous types of primary chondrosarcoma exist, namely conventional central (intramedullary), periosteal (juxta-cortical), clear cell, mesenchymal, and dedifferentiated. The biologic aggressiveness, prognosis and thus management of chondrosarcoma are dependent on the histological sub-type and grade. Accurate pre-operative diagnosis is therefore essential in determining management and outcome which requires a multidisciplinary approach taking into account clinical features, imaging findings and histopathology. In this review, we present the pertinent multimodality imaging features which aid in the differentiation of low-grade and high-grade conventional central chondrosarcoma.
Article
Objective To determine the rate of chondrosarcoma in incidentally discovered painless long bone cartilage lesions and to determine if any further imaging is needed.Materials and methodsA cartilage lesion was said to be an enchondroma when it had characteristic matrix mineralization and no aggressive features. Search of all imaging reports and tumor board files for keywords enchondroma, cartilage lesion, chondroid, and chondrosarcoma. Retrospective review of medical records and imaging studies from 4.5-year period. Data points collected included patient age, sex, lesion site, size, symptoms, type of imaging, imaging appearance, and length of follow-up. Only patients with no pain were included as enchondroma. Patients with final diagnosis of chondrosarcoma were included for comparison of all features.ResultsOnly 1/73 (1.4%) patients with an initial incidentally discovered painless lesion was later diagnosed, with new symptoms, as atypical cartilage tumor. Average age was 59.4 years. Bones involved were the femur (n = 33), humerus (n = 30), tibia (n = 7), fibula (n = 2), and ulna (n = 1). Average enchondroma size was 3.9 cm (range 1.4–11.5). Average follow-up was 47 months (range 2–196 months). Eleven long bone chondrosarcomas were identified. All chondrosarcoma patients had pain and aggressive imaging findings.Conclusion Our study reveals that the rate of chondrosarcoma in incidentally found painless chondroid lesions without aggressive features in long bones is low. Imaging follow-up may be needed only in the setting of new symptoms.
Article
Full-text available
Introduction: The purpose of our study is to verify possible clinical and radiological findings with regard to distinguishing enchondroma from atypical cartilaginous tumour (ACT). In addition, this study determined risk factors that are associated with local recurrence of enchondroma or ACT treated with curettage. Materials and methods: We retrospectively reviewed the records of 54 patients with enchondroma and 35 patients with ACT of the long bones treated by curettage between 1986 and 2015. The minimum follow-up was 18 months. The relationship between clinical and radiological factors and the tumour type or local recurrence was assessed using Chi-square test or Fischer exact test. Results: Endosteal scalloping (p = 0.004) and soft tissue extension (p = 0.017) were shown to statistically favour ACT over enchondroma; by contrast, pain (p = 0.034) was more frequent in enchondroma compared to ACT. All patients with enchondroma had no local recurrence; in contrast, local recurrence occurred in four patients with ACT (11%). Soft tissue extension (p = 0.049) and the diagnosis of ACT (p = 0.021) were associated with an increased risk of local recurrence. We had a disease progression in three of four patients with local recurrence, and these had higher histological grade than the original tumour. Discussion: Our data show that endosteal scalloping and soft tissue extension could be helpful in the differential diagnosis between enchondroma and ACT. We suggest following only those patients with ACT after surgery to identify any possible recurrence and, in case of recurrence, treat these patients with resection for the risk of disease progression.
Article
Full-text available
The gold standard treatment for enchondroma in the hand is curettage and filling of the defect. The goal of this study was to evaluate the results when injectable calcium phosphate cement is used to fill the bone defect. Eight patients having a mean age of 44 years were operated through a minimally invasive skin incision. After a small bone window was made, curettage of the lesion was performed and verified by intraosseous endoscopy. The defect was filled with injectable calcium phosphate cement (JectOS/AREX®BONE, Kasios, L’Union France). The mean pain score (out of 10) decreased from 4.1 preoperatively to 1.6 postoperatively. The mean QuickDASH (out of 100) improved from 37.66 to 24.14. At the last follow-up (mean of 16 months), the range of motion in the operated hand had reached 89.3% of the contralateral hand. Based on radiographs, a mean of 69.3% calcium phosphate cement remained in the bone. There were two cases of extraosseous cement leakage, one of which required revision and resulted in a poor outcome. Overall, these results show that curettage of a hand enchondroma followed by filling of the defect with injectable calcium phosphate cement is a simple, reliable technique with no donor site morbidity, as long as cement does not leak out.
Article
Full-text available
Background and objectives: Both enchondroma and atypical cartilaginous tumors (ACT) are not considered malignant, so inactive and asymptomatic tumors might not need surgery. To the best of our knowledge, this is the first study that has been done to evaluate the natural course of conservative-treated enchondroma and ACT in the long bones. Methods: For this retrospective study, we analyzed the results of patients in whom we refrained from surgery and only regularly performed radiological follow-up of the tumor. Minimal follow-up after initial diagnosis was 24 months. Results: Forty-nine patients were included in this study. Eight out of forty-nine cases received surgical treatment during follow-up of the tumor. The reasons for this surgery were radiologic growth of the tumor in two cases, pain in one case, patient request in three cases, another indication for surgery in the same limb in two cases. Conclusion: In this small series of conservatively treated enchondroma and ACT, only 6% of the patients had a medical indication for surgery. This study shows that indication for surgery should be discussed more thoroughly. Based on our results, we would recommend annual radiologic follow-up for asymptomatic enchondroma or ACT in the long bones, irrespective of tumor size. J. Surg. Oncol. 2016;114:987-991. © 2016 Wiley Periodicals, Inc.
Article
Full-text available
Background Various treatment strategies for low-grade chondrosarcomas with variable outcomes have been reported in the literature. The aim of this study was to assess the oncological and functional outcomes associated with intralesional curettage followed by adjuvant therapy comprising high-speed burring, thermal cauterization, and bone cementation with polymethylmethacrylate. Methods We performed a retrospective review of 21 consecutive patients with intramedullary low-grade chondrosarcoma of long bones treated by intralesional curettage and adjuvant therapy comprising high-speed burring, thermal cauterization, and cementation at our institution from 2007 to 2012. Results The average age of the patients was 48.7 (range, 18–71) years. There were 7 male and 14 female patients. The mean follow-up period was 58.4 (range, 26–85) months after surgery. The treated lesions were located in the proximal humerus (n =10), proximal tibia (n =6), and distal femur (n =5). At the average follow-up time point of 58.4 (range, 26–85) months, no patient had developed local recurrence and no distant metastases were observed. The average Musculoskeletal Tumor Society score among all 21 patients was 95% (84–100). Conclusions The combination of intralesional curettage, application of high-speed burring, thermal cauterization, and cementation is an effective treatment strategy for low-grade intramedullary chondrosarcoma of long bones. Excellent oncological and functional results can be obtained.
Article
Full-text available
Bone sarcomas are a variety of non-epithelial, malignant neoplasms of bone. The most common bone sarcomas are osteosarcoma, Ewing's sarcoma, and chondrosarcoma. The approach to a patient with a suspected bone sarcoma from initial examination to the histological diagnosis and classification is staging. Staging is of critical importance, in order to classify different treatment options and point out which combination of them is more suitable depending on the severity of the tumor in every individual patient. Staging should include medical history, physical and imaging examination, and biopsy. This article presents the current approach for staging, principles of biopsy, tumor classification, treatment, and follow-up of patients with bone sarcomas.
Article
Background: Little is known about the metastatic potential of low-grade chondrosarcoma. This study was designed to evaluate the rate of metastasis to identify possible risk factors. Methods: The files of 225 patients with newly diagnosed, grade I chondrosarcoma of bone treated between 1975 and 2012 were retrospectively analyzed. Median follow-up was 80 months for survivors (range 24-445 months). Nonparametric analyses were performed with the Mann-Whitney U test. Survival curves were calculated with the Kaplan-Meier method and compared with the log-rank test. Results: Fourteen patients developed metastases after a median of 49 months. Metastasis-free survival probability (MFS) was 95 % at 5 years and 92 % at 10 years. Post-metastasis survival probability amounted to 27 % after 5 years. Tumor size at diagnosis (P = 0.698) and surgical margin width (P = 0.514) had no influence on MFS. Patients who developed local recurrences had a significantly lower 10-year MFS than patients without recurrences (69 % vs. 99 %, P < 0.001). Patients with grade I recurrences had a significantly poorer MFS than patients without recurrences (P = 0.013) but a significantly higher MFS than patients with grade II recurrences (P = 0.006). Patients with thoracic wall tumors had a significantly lower 10-year MFS of 66 % compared with patients with tumors of the upper (100 %, P < 0.001) and lower extremity (93 %, P = 0.033). Conclusions: The biological behavior of low-grade chondrosarcoma appears to be more consistent with the WHO definition of rarely metastasizing bone tumors, rather than the one of locally aggressive neoplasms. Thoracic wall tumors and the development of local recurrences were associated with a higher metastasis rate in this study.
Article
Definition Subacromial shoulder pain is commonly located to the top and lateral side of the shoulder. It is exaggerated by overhead activity and can be associated with night pain. It is usually associated with full passive range of movement of the glenohumeral joint. The pain originates from the subacromial space of the shoulder, an area made up of the rotator cuff tendons and the subacromial bursa. This area is separate to the main glenohumeral joint. Pain from this area is mainly caused by rotator cuff tendinopathy, also referred to as ‘shoulder impingement’. Impingement occurs between the undersurface of the acromion (roof of shoulder) and the rotator cuff tendons. These tendons can be either intact or torn. A number of other terms such as supraspinatus tendinopathy, tendinitis and bursitis are also used across different disciplines but the diagnosis is essentially the same and referred to in this document as rotator cuff tendinopathy/impingement.
Article
Background: The prevalence and cost of unnecessary advanced imaging studies (AIS) in the evaluation of long bone cartilaginous lesions have not been studied previously. Methods: A total of 105 enchondromas and 19 chondrosarcomas arising in long bones from July 2008 until April 2012 in 121 patients were reviewed. Advanced imaging was defined as MRI, CT, bone scan, skeletal survey, or CT biopsy. Two blinded radiologists independently reviewed the initial imaging study and determined if further imaging was indicated based on that imaging study alone. The cost of imaging was taken from our institution's global charge list. Imaging was deemed unnecessary if it was not recommended by our radiologists after review of the initial imaging study. The difference in cost was calculated by subtracting the cost of imaging recommended by each radiologist from the cost of unnecessary imaging. The sensitivity and specificity for distinguishing enchondromas from chondrosarcomas was calculated. A minimum of 2 years from diagnosis of an enchondroma was required to monitor for malignant transformation. Results: Of patients diagnosed with an enchondroma, 85 % presented with AIS. The average enchondroma patient presented with one unnecessary AIS. The radiologists' interpretations agreed 85 % of the time for enchondromas and 100 % for chondrosarcomas. The sensitivity and specificity for distinguishing enchondromas from chondrosarcomas was 95 % for one radiologist and 87 and 95 % for the other. The average unnecessary cost per enchondroma patient was $1,346.18. Conclusions: Unnecessary AIS are frequently performed and are a significant source of expense. The imaging algorithms outlined in this study may reduce unnecessary AIS.
Article
Objectives: To identify magnetic resonance imaging (MRI) features which differentiate low-grade chondral lesions (atypical cartilaginous tumours/grade 1 chondrosarcoma) from high-grade chondrosarcomas (grade 2, grade 3 and dedifferentiated chondrosarcoma) of the major long bones. Methods: We identified all patients treated for central atypical cartilaginous tumours and central chondrosarcoma of major long bones (humerus, femur, tibia) over a 13-year period. The MRI studies were assessed for the following features: bone marrow oedema, soft tissue oedema, bone expansion, cortical thickening, cortical destruction, active periostitis, soft tissue mass and tumour length. The MRI-features were compared with the histopathological tumour grading using univariate, multivariate logistic regression and receiver operating characteristic curve (ROC) analyses. Results: One hundred and seventy-nine tumours were included in this retrospective study. There were 28 atypical cartilaginous tumours, 79 grade 1 chondrosarcomas, 36 grade 2 chondrosarcomas, 13 grade 3 chondrosarcomas and 23 dedifferentiated chondrosarcomas. Multivariate analysis demonstrated that bone expansion (P = 0.001), active periostitis (P = 0.001), soft tissue mass (P < 0.001) and tumour length (P < 0.001) were statistically significant differentiating factors between low-grade and high-grade chondral lesions with an area under the ROC curve of 0.956. Conclusions: On MRI, bone expansion, active periostitis, soft tissue mass and tumour length can reliably differentiate high-grade chondrosarcomas from low-grade chondral lesions of the major long bones. Key points: • Accurate differentiation of low-grade from high-grade chondrosarcomas is essential before surgery • MRI can reliably differentiate high-grade from low-grade chondrosarcomas of long bone • Differentiating features are bone expansion, periostitis, soft tissue mass and tumour length • Presence of these four MRI features demonstrated a diagnostic accuracy (AUC) of 95.6 % • The findings may result in more accurate diagnosis before definitive surgery.